141 related articles for article (PubMed ID: 4055062)
1. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
Fujii R
Infection; 1985; 13 Suppl 1():S9-13. PubMed ID: 4055062
[TBL] [Abstract][Full Text] [Related]
2. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Richards DM; Heel RC
Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
[TBL] [Abstract][Full Text] [Related]
3. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
Iannini PB
Infection; 1985; 13 Suppl 1():S3-6. PubMed ID: 4055052
[TBL] [Abstract][Full Text] [Related]
4. Cefotaxime in the treatment of staphylococcal infections. Comparison of in vitro and in vivo studies.
Aldridge KE
Diagn Microbiol Infect Dis; 1995; 22(1-2):195-201. PubMed ID: 7587040
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
[TBL] [Abstract][Full Text] [Related]
6. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
Francke EL; Neu HC
Am J Med; 1981 Sep; 71(3):435-42. PubMed ID: 6269426
[TBL] [Abstract][Full Text] [Related]
7. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
Steed ME; Rybak MJ
Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458
[TBL] [Abstract][Full Text] [Related]
8. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
Karakusis PH; Trenholme GM; Levin S
Infection; 1985; 13 Suppl 1():S46-9. PubMed ID: 4055055
[TBL] [Abstract][Full Text] [Related]
9. Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.
Helwig HF
Infection; 1985; 13 Suppl 1():S62-7. PubMed ID: 4055057
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
Bassetti D; Solbiati M; Fraizzoli G
Infection; 1985; 13 Suppl 1():S112-4. PubMed ID: 4055040
[TBL] [Abstract][Full Text] [Related]
11. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
12. [Bacteriological and clinical studies on cefotaxime in obstetrics and gynecology (author's transl)].
Ninomiya K; Hasegawa Y; Hamatani K; Nishio T
Jpn J Antibiot; 1981 Apr; 34(4):507-14. PubMed ID: 6270399
[TBL] [Abstract][Full Text] [Related]
13. Cephalosporins--cefotaxime 10 years later, a major drug with continued use.
Neu HC
Infection; 1991; 19 Suppl 6():S309-15. PubMed ID: 1791075
[TBL] [Abstract][Full Text] [Related]
14. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
15. Cefotaxime for the treatment of gram-positive urinary tract infection.
Piccinno A; Pagliarulo A
Infection; 1985; 13 Suppl 1():S100-2. PubMed ID: 4055038
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of cefotaxime in gram-positive surgical infections.
Wittmann DH; Frommelt L
Infection; 1985; 13 Suppl 1():S37-42. PubMed ID: 4055054
[TBL] [Abstract][Full Text] [Related]
17. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
Gimeno C; Borja J; Navarro D; Valdés L; García-Barbal J; García-de-Lomas J
Chemotherapy; 1998; 44(2):94-8. PubMed ID: 9551238
[TBL] [Abstract][Full Text] [Related]
18. Cefotaxime. An update of its pharmacology and therapeutic use.
Todd PA; Brogden RN
Drugs; 1990 Oct; 40(4):608-51. PubMed ID: 2083516
[TBL] [Abstract][Full Text] [Related]
19. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
Norrby SR
Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime in the treatment of meningitis.
Cherubin CE; LeFrock J
Infection; 1985; 13 Suppl 1():S68-72. PubMed ID: 4055058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
